Joe Bress is a Managing Director at Carlyle in Americas private equity, focusing on investments in the healthcare sector. He is based in New York. Since joining Carlyle in 2007, Joe has been actively involved with Carlyle’s investments in Included Health, Rede D’Or São Luiz S.A., Curia Global, Inc., CorroHealth, X‐Chem, CorroHealth, Millicent Pharma Limited, Pharmaceutical Product Development, Inc., Saama, TriNetX, LLC and WellDyneRx, LLC. Prior to Carlyle, Joe worked in the Mergers & Acquisitions group at UBS. Joe serves as a director on the boards of Curia Global, CorroHealth, Millicent Pharma Limited, Saama, TriNetX, LLC and WellDyneRx, LLC. Joe received his M.B.A. from Stanford University and an A.B. from Harvard University, where he graduated magna cum laude.